NewHydrogen has finished building and commissioning its ThermoLoop engineering test unit (ETU), enabling continuous operation to demonstrate long-term stability and gather data for designing its first commercial pilot plant. This milestone bridges lab experiments and industrial-scale production, aiming to produce clean hydrogen at a scale competitive with fossil fuel methods. The pilot plant will pave the way for large-scale industrial facilities to meet growing global demand for clean hydrogen, which is crucial for reducing fossil fuel reliance in industries like fertilizer production and steelmaking. The ThermoLoop process uses heat to split water, offering a cost-effective alternative to traditional electrolysis methods.
NewHydrogen's completion of its ThermoLoop engineering test unit offers context for energy sector trends. For readers following the energy sector, here is Pluang's market snapshot as of Oct 20, 2026 01:32 WIB: out of 79 priced US energy stocks, 19 rose and 60 fell. Notable movers include PBF Energy Inc. Class A Common Stock at USD 80.83 with a 1-day change of -4.37% and Pluang order activity showing 0% Sell / 100% Buy, Valaris Limited Common Shares at USD 88.52 with a 1-day change of +3.74%, and Solaris Energy Infrastructure Inc. Class A Common Stock at USD 65.06 with a 1-day change of +3.70% and balanced Pluang order activity of 50% Sell / 50% Buy.
The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...
The HCA Healthcare Foundation awarded $25,000 to Waypoint (formerly Virginia Home for Boys and Girls) to expand its network of adults trained to support youth mental wellness across Virginia. This funding supports Waypoint's Therapeutic Resources tea...
Angle Advisors has appointed Chris Gessner as a Managing Director, bringing over 20 years of experience in corporate finance, including lending, private equity, and M&A advisory. Gessner's background spans various transaction types and industries suc...
The FDA has approved Jemperli (dostarlimab) as the first immunotherapy for adults with stage II and III MSI-H/dMMR locally advanced rectal cancer. This approval is based on the AZUR-1 trial showing 68% of patients achieved complete clinical response ...
Ethereum-based crypto Pepeto is in its final presale stages ahead of a Binance listing, with rapid investor interest driving record presale speed. Pepeto addresses issues Cardano aimed to fix, such as high fees and network congestion, offering zero-f...
